Three Bridge Wealth Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
KCM
BBA
Three Bridge Wealth Advisors's CLDX Position: Q3 2026 in Review
Three Bridge Wealth Advisors opened a new position in Celldex Therapeutics (CLDX) in Q3 2026: 1,248 shares worth $40.4K. The stake represents 0.01% of the portfolio and ranks #167 among its holdings.
249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.
- Three Bridge Wealth Advisors held 1,248 shares of Celldex Therapeutics worth $40.4K as of Q3 2026.
- Celldex Therapeutics was a new Three Bridge Wealth Advisors position in Q3 2026.
- Celldex Therapeutics made up 0.01% of Three Bridge Wealth Advisors's portfolio in Q3 2026, its #167 holding.
- 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.
Based on Three Bridge Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.